These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19016574)

  • 1. Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis.
    Athanassa Z; Makris G; Dimopoulos G; Falagas ME
    Drugs; 2008; 68(17):2469-81. PubMed ID: 19016574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
    Nathan RV; Rhew DC; Murray C; Bratzler DW; Houck PM; Weingarten SR
    Am J Med; 2006 Jun; 119(6):512.e1-7. PubMed ID: 16750965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
    Zervos M; Mandell LA; Vrooman PS; Andrews CP; McIvor A; Abdulla RH; de Caprariis PJ; Knirsch CA; Amsden GW; Niederman MS; Lode H
    Treat Respir Med; 2004; 3(5):329-36. PubMed ID: 15606222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial.
    Castro-Guardiola A; Viejo-Rodríguez AL; Soler-Simon S; Armengou-Arxé A; Bisbe-Company V; Peñarroja-Matutano G; Bisbe-Company J; García-Bragado F
    Am J Med; 2001 Oct; 111(5):367-74. PubMed ID: 11583639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial.
    Oosterheert JJ; Bonten MJ; Schneider MM; Buskens E; Lammers JW; Hustinx WM; Kramer MH; Prins JM; Slee PH; Kaasjager K; Hoepelman AI
    BMJ; 2006 Dec; 333(7580):1193. PubMed ID: 17090560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis.
    Rhew DC; Tu GS; Ofman J; Henning JM; Richards MS; Weingarten SR
    Arch Intern Med; 2001 Mar; 161(5):722-7. PubMed ID: 11231705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis.
    Dimopoulos G; Matthaiou DK; Karageorgopoulos DE; Grammatikos AP; Athanassa Z; Falagas ME
    Drugs; 2008; 68(13):1841-54. PubMed ID: 18729535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial.
    Carratalà J; Garcia-Vidal C; Ortega L; Fernández-Sabé N; Clemente M; Albero G; López M; Castellsagué X; Dorca J; Verdaguer R; Martínez-Montauti J; Manresa F; Gudiol F
    Arch Intern Med; 2012 Jun; 172(12):922-8. PubMed ID: 22732747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010-2018.
    Kimura T; Ito M; Onozawa S
    J Infect Chemother; 2020 Jul; 26(7):706-714. PubMed ID: 32284180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.
    Kohno S; Yanagihara K; Yamamoto Y; Tokimatsu I; Hiramatsu K; Higa F; Tateyama M; Fujita J; Kadota J
    J Infect Chemother; 2013 Dec; 19(6):1035-41. PubMed ID: 23695232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
    Lode H; File TM; Mandell L; Ball P; Pypstra R; Thomas M;
    Clin Ther; 2002 Nov; 24(11):1915-36. PubMed ID: 12501883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When to switch therapy in patients with severe community-acquired pneumonia.
    Mortensen EM; Restrepo MI; Anzueto A
    Ann Intern Med; 2008 Apr; 148(8):625; author reply 625-6. PubMed ID: 18413627
    [No Abstract]   [Full Text] [Related]  

  • 13. Switch therapy in hospitalized patients with community-acquired pneumonia: tigecycline vs. levofloxacin.
    Ramirez JA; Cooper AC; Wiemken T; Gardiner D; Babinchak T;
    BMC Infect Dis; 2012 Jul; 12():159. PubMed ID: 22812672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of early switch from intravenous to oral antimicrobials in patients with aspiration pneumonia: A prospective observational study.
    Uni M; Nishimura N; Yamano Y; Ishikawa G; Kitamura A; Tomishima Y; Jinta T; Takahashi O; Deshpande G; Chohnabayashi N
    Respir Investig; 2015 Sep; 53(5):225-31. PubMed ID: 26344612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.
    File TM; Rewerska B; Vucinic-Mihailovic V; Gonong JRV; Das AF; Keedy K; Taylor D; Sheets A; Fernandes P; Oldach D; Jamieson BD
    Clin Infect Dis; 2016 Oct; 63(8):1007-1016. PubMed ID: 27448679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization.
    Mikami K; Suzuki M; Kitagawa H; Kawakami M; Hirota N; Yamaguchi H; Narumoto O; Kichikawa Y; Kawai M; Tashimo H; Arai H; Horiuchi T; Sakamoto Y
    Lung; 2007; 185(5):249-255. PubMed ID: 17710485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Duration of treatment and oral administrad on of antibiotics in community acquired pneumonia].
    Bernal-Vargas MA; Cortés JA
    Rev Chilena Infectol; 2016 Apr; 33(2):177-86. PubMed ID: 27314995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
    Lee RW; Lindstrom ST
    Respirology; 2007 Jan; 12(1):111-6. PubMed ID: 17207035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials.
    Niederman MS; Chang JR; Stewart J; Asche CV; Lavin B; Nusrat R; Sullivan SD
    Curr Med Res Opin; 2004 Jul; 20(7):969-80. PubMed ID: 15265241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for early discharge of the hospitalized patient with community-acquired pneumonia.
    Siegel RE
    Clin Chest Med; 1999 Sep; 20(3):599-605. PubMed ID: 10516907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.